Illumina Countersues Life Technologies in Ongoing Sequencing Patent Row | GenomeWeb

NEW YORK (GenomeWeb News) — Illumina and its Solexa subsidiary today said that they have filed a countersuit in response to a DNA sequencing patent-infringement lawsuit brought against them last month by Life Technologies and its subsidiary Applied Biosystems.

In their filing, Illumina and Solexa have denied all of Life's and ABI's allegations of patent infringement, and they have asserted that ABI's licensed patents are invalid.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.